SAN CARLOS, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next-generation, potentially curative cell ...

PBFT02 demonstrated durable, elevated CSF PGRN levels and early evidence of reduction in plasma <a target=_blank href= ...

Phase 2 clinical study of firicabtagene autoleucel (firi-cel); Interim analysis results expected to be reported in 1H'25 - - IND application for CRG-023 ...

From the first day in office, the Biden-Harris Administration has been committed to supporting the recovery and modernization of Puerto Rico's energy ...